Coverage
-
April 26, 2017
A Delaware federal judge on Wednesday dismissed a 5-year-old lawsuit alleging Allergan Inc. conspired with other pharmaceutical companies to stifle competition for its Zymar pinkeye treatment after the company announced it had reached a settlement with generics maker Apotex Inc.
5 other articles on this case.
View all »